世界のサイトメガロウイルス（CMV）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cytomegalovirus Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1707 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、サイトメガロウイルス（CMV）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ガンシクロビル/バルガンシクロビル、ホスカルネット、シドフォビル）、用途別市場規模（CMV網膜炎、肺炎、消化性潰瘍、脳炎、口内潰瘍、咽頭炎）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・サイトメガロウイルス（CMV）治療の市場動向 ・企業の競争状況、市場シェア ・サイトメガロウイルス（CMV）治療の種類別市場規模（ガンシクロビル/バルガンシクロビル、ホスカルネット、シドフォビル） ・サイトメガロウイルス（CMV）治療の用途別市場規模（CMV網膜炎、肺炎、消化性潰瘍、脳炎、口内潰瘍、咽頭炎） ・サイトメガロウイルス（CMV）治療の北米市場規模2016-2027（アメリカ、カナダ） ・サイトメガロウイルス（CMV）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・サイトメガロウイルス（CMV）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サイトメガロウイルス（CMV）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・サイトメガロウイルス（CMV）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Actavis、Clinigen Group、Merck、Perrigo Company、Roche、Bausch Health） ・結論

Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market
The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cytomegalovirus Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cytomegalovirus Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cytomegalovirus Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cytomegalovirus Therapeutics market.

Global Cytomegalovirus Therapeutics Scope and Market Size
Cytomegalovirus Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ganciclovir/Valganciclovir
Foscarnet
Cidofovir

Segment by Application
CMV Retinitis
Pneumonia
Gastrointestinal Ulcers
Encephalitis
Mouth Ulcers
Pharyngitis

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Actavis
Clinigen Group
Merck
Perrigo Company
Roche
Bausch Health

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytomegalovirus Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ganciclovir/Valganciclovir
1.2.3 Foscarnet
1.2.4 Cidofovir
1.3 Market by Application
1.3.1 Global Cytomegalovirus Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 CMV Retinitis
1.3.3 Pneumonia
1.3.4 Gastrointestinal Ulcers
1.3.5 Encephalitis
1.3.6 Mouth Ulcers
1.3.7 Pharyngitis
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cytomegalovirus Therapeutics Market Perspective (2016-2027)
2.2 Cytomegalovirus Therapeutics Growth Trends by Regions
2.2.1 Cytomegalovirus Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cytomegalovirus Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Cytomegalovirus Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Cytomegalovirus Therapeutics Industry Dynamic
2.3.1 Cytomegalovirus Therapeutics Market Trends
2.3.2 Cytomegalovirus Therapeutics Market Drivers
2.3.3 Cytomegalovirus Therapeutics Market Challenges
2.3.4 Cytomegalovirus Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus Therapeutics Players by Revenue
3.1.1 Global Top Cytomegalovirus Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Cytomegalovirus Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Cytomegalovirus Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cytomegalovirus Therapeutics Revenue
3.4 Global Cytomegalovirus Therapeutics Market Concentration Ratio
3.4.1 Global Cytomegalovirus Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Therapeutics Revenue in 2020
3.5 Cytomegalovirus Therapeutics Key Players Head office and Area Served
3.6 Key Players Cytomegalovirus Therapeutics Product Solution and Service
3.7 Date of Enter into Cytomegalovirus Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cytomegalovirus Therapeutics Breakdown Data by Type
4.1 Global Cytomegalovirus Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Cytomegalovirus Therapeutics Forecasted Market Size by Type (2022-2027)

5 Cytomegalovirus Therapeutics Breakdown Data by Application
5.1 Global Cytomegalovirus Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Cytomegalovirus Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cytomegalovirus Therapeutics Market Size (2016-2027)
6.2 North America Cytomegalovirus Therapeutics Market Size by Type
6.2.1 North America Cytomegalovirus Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Cytomegalovirus Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Cytomegalovirus Therapeutics Market Size by Type (2016-2027)
6.3 North America Cytomegalovirus Therapeutics Market Size by Application
6.3.1 North America Cytomegalovirus Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Cytomegalovirus Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Cytomegalovirus Therapeutics Market Size by Application (2016-2027)
6.4 North America Cytomegalovirus Therapeutics Market Size by Country
6.4.1 North America Cytomegalovirus Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Cytomegalovirus Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cytomegalovirus Therapeutics Market Size (2016-2027)
7.2 Europe Cytomegalovirus Therapeutics Market Size by Type
7.2.1 Europe Cytomegalovirus Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Cytomegalovirus Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Cytomegalovirus Therapeutics Market Size by Type (2016-2027)
7.3 Europe Cytomegalovirus Therapeutics Market Size by Application
7.3.1 Europe Cytomegalovirus Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Cytomegalovirus Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Cytomegalovirus Therapeutics Market Size by Application (2016-2027)
7.4 Europe Cytomegalovirus Therapeutics Market Size by Country
7.4.1 Europe Cytomegalovirus Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Cytomegalovirus Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cytomegalovirus Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Type
8.2.1 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Application
8.3.1 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Region
8.4.1 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cytomegalovirus Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cytomegalovirus Therapeutics Market Size (2016-2027)
9.2 Latin America Cytomegalovirus Therapeutics Market Size by Type
9.2.1 Latin America Cytomegalovirus Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Cytomegalovirus Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Cytomegalovirus Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Cytomegalovirus Therapeutics Market Size by Application
9.3.1 Latin America Cytomegalovirus Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Cytomegalovirus Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Cytomegalovirus Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Cytomegalovirus Therapeutics Market Size by Country
9.4.1 Latin America Cytomegalovirus Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Cytomegalovirus Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cytomegalovirus Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Type
10.2.1 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Application
10.3.1 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Country
10.4.1 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cytomegalovirus Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Cytomegalovirus Therapeutics Introduction
11.1.4 AbbVie Revenue in Cytomegalovirus Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Actavis
11.2.1 Actavis Company Details
11.2.2 Actavis Business Overview
11.2.3 Actavis Cytomegalovirus Therapeutics Introduction
11.2.4 Actavis Revenue in Cytomegalovirus Therapeutics Business (2016-2021)
11.2.5 Actavis Recent Development
11.3 Clinigen Group
11.3.1 Clinigen Group Company Details
11.3.2 Clinigen Group Business Overview
11.3.3 Clinigen Group Cytomegalovirus Therapeutics Introduction
11.3.4 Clinigen Group Revenue in Cytomegalovirus Therapeutics Business (2016-2021)
11.3.5 Clinigen Group Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Cytomegalovirus Therapeutics Introduction
11.4.4 Merck Revenue in Cytomegalovirus Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Perrigo Company
11.5.1 Perrigo Company Company Details
11.5.2 Perrigo Company Business Overview
11.5.3 Perrigo Company Cytomegalovirus Therapeutics Introduction
11.5.4 Perrigo Company Revenue in Cytomegalovirus Therapeutics Business (2016-2021)
11.5.5 Perrigo Company Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Cytomegalovirus Therapeutics Introduction
11.6.4 Roche Revenue in Cytomegalovirus Therapeutics Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Cytomegalovirus Therapeutics Introduction
11.7.4 Bausch Health Revenue in Cytomegalovirus Therapeutics Business (2016-2021)
11.7.5 Bausch Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cytomegalovirus Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ganciclovir/Valganciclovir
Table 3. Key Players of Foscarnet
Table 4. Key Players of Cidofovir
Table 5. Global Cytomegalovirus Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cytomegalovirus Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cytomegalovirus Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cytomegalovirus Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Cytomegalovirus Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cytomegalovirus Therapeutics Market Share by Regions (2022-2027)
Table 11. Cytomegalovirus Therapeutics Market Trends
Table 12. Cytomegalovirus Therapeutics Market Drivers
Table 13. Cytomegalovirus Therapeutics Market Challenges
Table 14. Cytomegalovirus Therapeutics Market Restraints
Table 15. Global Cytomegalovirus Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cytomegalovirus Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Cytomegalovirus Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Therapeutics as of 2020)
Table 18. Ranking of Global Top Cytomegalovirus Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cytomegalovirus Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cytomegalovirus Therapeutics Product Solution and Service
Table 22. Date of Enter into Cytomegalovirus Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cytomegalovirus Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cytomegalovirus Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Cytomegalovirus Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cytomegalovirus Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cytomegalovirus Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cytomegalovirus Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Cytomegalovirus Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cytomegalovirus Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cytomegalovirus Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cytomegalovirus Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cytomegalovirus Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cytomegalovirus Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cytomegalovirus Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cytomegalovirus Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cytomegalovirus Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cytomegalovirus Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cytomegalovirus Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cytomegalovirus Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cytomegalovirus Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cytomegalovirus Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cytomegalovirus Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cytomegalovirus Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cytomegalovirus Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cytomegalovirus Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cytomegalovirus Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cytomegalovirus Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cytomegalovirus Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cytomegalovirus Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cytomegalovirus Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cytomegalovirus Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cytomegalovirus Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cytomegalovirus Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cytomegalovirus Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cytomegalovirus Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cytomegalovirus Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cytomegalovirus Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cytomegalovirus Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cytomegalovirus Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie Company Details
Table 63. AbbVie Business Overview
Table 64. AbbVie Cytomegalovirus Therapeutics Product
Table 65. AbbVie Revenue in Cytomegalovirus Therapeutics Business (2016-2021) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Actavis Company Details
Table 68. Actavis Business Overview
Table 69. Actavis Cytomegalovirus Therapeutics Product
Table 70. Actavis Revenue in Cytomegalovirus Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Actavis Recent Development
Table 72. Clinigen Group Company Details
Table 73. Clinigen Group Business Overview
Table 74. Clinigen Group Cytomegalovirus Therapeutics Product
Table 75. Clinigen Group Revenue in Cytomegalovirus Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Clinigen Group Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Cytomegalovirus Therapeutics Product
Table 80. Merck Revenue in Cytomegalovirus Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Perrigo Company Company Details
Table 83. Perrigo Company Business Overview
Table 84. Perrigo Company Cytomegalovirus Therapeutics Product
Table 85. Perrigo Company Revenue in Cytomegalovirus Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Perrigo Company Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Cytomegalovirus Therapeutics Product
Table 90. Roche Revenue in Cytomegalovirus Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. Bausch Health Company Details
Table 93. Bausch Health Business Overview
Table 94. Bausch Health Cytomegalovirus Therapeutics Product
Table 95. Bausch Health Revenue in Cytomegalovirus Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Bausch Health Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Ganciclovir/Valganciclovir Features
Figure 3. Foscarnet Features
Figure 4. Cidofovir Features
Figure 5. Global Cytomegalovirus Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. CMV Retinitis Case Studies
Figure 7. Pneumonia Case Studies
Figure 8. Gastrointestinal Ulcers Case Studies
Figure 9. Encephalitis Case Studies
Figure 10. Mouth Ulcers Case Studies
Figure 11. Pharyngitis Case Studies
Figure 12. Cytomegalovirus Therapeutics Report Years Considered
Figure 13. Global Cytomegalovirus Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Cytomegalovirus Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Cytomegalovirus Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Cytomegalovirus Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Cytomegalovirus Therapeutics Market Share by Players in 2020
Figure 18. Global Top Cytomegalovirus Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Cytomegalovirus Therapeutics Revenue in 2020
Figure 20. Global Cytomegalovirus Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Cytomegalovirus Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Cytomegalovirus Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Cytomegalovirus Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Cytomegalovirus Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cytomegalovirus Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Cytomegalovirus Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Cytomegalovirus Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cytomegalovirus Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Cytomegalovirus Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Cytomegalovirus Therapeutics Market Share by Region (2016-2027)
Figure 42. China Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cytomegalovirus Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Cytomegalovirus Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Cytomegalovirus Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cytomegalovirus Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Cytomegalovirus Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Cytomegalovirus Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Cytomegalovirus Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AbbVie Revenue Growth Rate in Cytomegalovirus Therapeutics Business (2016-2021)
Figure 62. Actavis Revenue Growth Rate in Cytomegalovirus Therapeutics Business (2016-2021)
Figure 63. Clinigen Group Revenue Growth Rate in Cytomegalovirus Therapeutics Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Cytomegalovirus Therapeutics Business (2016-2021)
Figure 65. Perrigo Company Revenue Growth Rate in Cytomegalovirus Therapeutics Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Cytomegalovirus Therapeutics Business (2016-2021)
Figure 67. Bausch Health Revenue Growth Rate in Cytomegalovirus Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---